Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.

ABSTRACT:

Importance

The lymphatic and the hematogenous pathways have been proposed for disease progression in cutaneous melanoma, but association with recurrence has not been studied separately to date.

Objective

To identify the risk factors associated with lymphatic and hematogenous metastasis.

Design, setting, and participants

This retrospective cohort study included 1177 patients with malignant melanoma treated at Instituto Valenciano de Oncología, València, Spain. Data were retrieved from the melanoma database from January 1, 2000, through December 31, 2015, and analyzed from June 1 to 30, 2018.

Exposure

Malignant melanoma at stages I to II.

Main outcomes and measures

Analyses of survival free of lymphatic and hematogenous metastasis were performed using Kapl

SUBMITTER: Calomarde-Rees L 

PROVIDER: S-EPMC6495361 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature